Medical Marijuana’s Evolving Role in a Booming Cannabis Market

As cannabis legalization gains momentum, the focus on medical marijuana, while crucial, sometimes gets overshadowed by recreational use. This article delves into the unique challenges and opportunities facing the medical cannabis sector, exploring the intersection of tax incentives, state-level regulations, and the growing competition between medical and adult-use dispensaries.

Cannabis Industry Awaits Impact of Harris-Walz Ticket: Rescheduling or Full Legalization?

Laurie Parfitt, CEO of LKP Impact Consulting, provides insights into the potential impact of a Kamala Harris-Tim Walz presidency on the cannabis industry. While rescheduling cannabis is seen as a victory, concerns remain about the speed of full legalization. The industry awaits clarity on how federal policy will evolve, seeking a regulatory environment that allows businesses to thrive.

Black Cannabis Week: Empowering Philadelphia’s Communities in the Emerging Cannabis Industry

As Pennsylvania moves closer to legalizing recreational cannabis, Black Cannabis Week in Philadelphia is leading the charge for social equity in the burgeoning industry. This week-long event focuses on empowering Black and Latino entrepreneurs, advocating for legal reforms, and ensuring that the benefits of legalization reach communities disproportionately impacted by past marijuana laws.

Cannabis Sales Soar in North Carolina’s First Legal Dispensary, While Other States See New Store Openings

Cannabis sales are booming in North Carolina’s first recreational marijuana dispensary, Great Smoky, located on the Qualla Boundary of the Eastern Band of Cherokee Indians. Meanwhile, multiple new cannabis dispensaries have opened in Florida, New York, Vermont, Illinois, Pennsylvania, Louisiana, and California, highlighting the growing legalization and accessibility of cannabis across the United States.

Cannabis Legalization and Mental Health Medications: A Complex Relationship

A new study published in JAMA Network Open explores how cannabis legalization, both medical and recreational, is affecting the prescription of mental health medications in the U.S. The findings reveal a complex relationship, with cannabis laws leading to both decreased benzodiazepine prescriptions and increased use of antidepressants and antipsychotics. This underscores the need for further research into the broader impact of cannabis legalization on mental health treatment.

Scroll to Top